Cognitive functions and white matter lesions on magnetic resonance images in a sample of normal Iranian population with cardiovascular risk factors

Abstract

Purpose

Due to a suggestive three-way relationship between brain structural disorders, microvascular lesions, and cognitive impairments, we aimed to examine the association of the volume and number of white matter hyperintensity lesions and lacunar infarcts with cognitive impairment among patients with cardiovascular risk factors in a sample of the Iranian population.

Materials and methods

This study was conducted on a total number of 156 normal subjects aged 30–74 years with cardiovascular risk factors. We used the Framingham general cardiovascular risk factors prediction model to calculate the likelihood of each risk factor. The total number of lacunar infarcts and the volume of white matter hyperintensity lesion were calculated in brain magnetic resonance imaging. Cognition status was assessed using the Montreal Cognitive Assessment questionnaire.

Results

An adverse association was revealed between Montreal Cognitive Assessment score and different cardiovascular risk profiles including the Framingham body mass index score (p < 0.001) and the Framingham lipid score (p < 0.001). The total volume of white matter hyperintensity was negatively associated with total Montreal Cognitive Assessment cognition score (p < 0.001). Our study also showed an adverse association between total number of lacunar infarcts and total Montreal Cognitive Assessment cognition score (p = 0.038) and with some cognition components including memory (p = 0.013), attention (p = 0.037), abstraction (p = 0.046), and orientation (p = 0.002).

Conclusion

Periventricular lesions are associated with impaired memory, language, and visuoconstruction while subcortical lesions are associated with impairment in naming, attention, language, and abstraction functions in normal subjects with cardiovascular risk factors but without cardiovascular or cerebrovascular disorders.

Keywords

Cognitive function microvascular lesion cardiovascular risk factors ischemia magnetic resonance imaging

Get full access to this article

View all access options for this article.

References

O'Brien

Erkinjuntti

Reisberg

et al.

Vascular cognitive impairment. Lancet Neurol 2003; 2: 89–98.

Satizabal

Beiser

Chouraki

et al.

Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med 2016; 374: 523–532.

Wolf

. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol 2012; 69: 567–571.

Jones

Greene

. Is dementia in decline? Historical trends and future trajectories. N Engl J Med 2016; 374: 507–509.

Tsubota-Utsugi

Satoh

Tomita

et al.

Lacunar infarcts rather than white matter hyperintensity as a predictor of future higher level functional decline: The Ohasama study. J Stroke Cerebrovasc Dis 2017; 26: 376–384.

Evans

O'Sullivan

de Groot

et al.

White matter microstructure improves stroke risk prediction in the general population. Stroke 2016; 47: 2756–2762.

Chui

Ramirez Gomez

. Vascular contributions to cognitive impairment in late life. Neurol Clin 2017; 35: 295–323.

Liu

et al.

Presence of lacunar infarctions is associated with the spatial navigation impairment in patients with mild cognitive impairment: A DTI study. Oncotarget 2016; 7: 78310–78319.

Angermann

Frey

Ertl

. Cognition matters in cardiovascular disease and heart failure. Eur Heart J 2012; 33: 1721–1723.

10.

Dixit

Vazquez

Cross

et al.

Cardiac resynchronization therapy: A pilot study examining cognitive change in patients before and after treatment. Clin Cardiol 2010; 33: 84–88.

11.

Lin

Blumenthal

Ellis

et al.

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301: 1451–1459.

12.

de Roos

van der Grond

Mitchell

et al.

Magnetic resonance imaging of cardiovascular function and the brain: Is dementia a cardiovascular-driven disease?

Circulation 2017; 135: 2178–2195.

13.

Geerlings

Appelman

Vincken

et al.

Association of white matter lesions and lacunar infarcts with executive functioning: The SMART-MR study. Am J Epidemiol 2009; 170: 1147–1155.

14.

Warren

Weiner

Rossetti

et al.

Cognitive impact of lacunar infarcts and white matter hyperintensity volume. Dement Geriatr Cogn Dis Extra 2015; 5: 170–175.

15.

Vermeer

Hollander

van Dijk

et al.

Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan study. Stroke 2003; 34: 1126–1129.

16.

Otani

Kikuya

Hara

et al.

Association of kidney dysfunction with silent lacunar infarcts and white matter hyperintensity in the general population: The Ohasama study. Cerebrovasc Dis 2010; 30: 43–50.

17.

Iseki

Hanakawa

Hashikawa

et al.

Gait disturbance associated with white matter changes: A gait analysis and blood flow study. Neuroimage 2010; 49: 1659–1666.

18.

Kreisel

Blahak

Bazner

et al.

Deterioration of gait and balance over time: The effects of age-related white matter change–the LADIS study. Cerebrovasc Dis 2013; 35: 544–553.

19.

Nasreddine

Phillips

Bedirian

et al.

The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695–699.

20.

Faraci

. Protecting against vascular disease in brain. Amer J Physiol 2011; 300: H1566–H1582.

21.

Iadecola

. The pathobiology of vascular dementia. Neuron 2013; 80: 844–866.

22.

Zimny

Szewczyk

Bladowska

et al.

Quantitative evaluation of changes in the selected white matter tracts using diffusion tensor imaging in patients with Alzheimer's disease and mild cognitive impairment. Neuroradiol J 2012; 25: 300–310.

23.

Papapostolou

Goutsaridou

Arvaniti

et al.

Is total brain volume correlated to cognitive function and education in patients with Alzheimer disease?

Neuroradiol J 2008; 21: 500–504.

24.

Ghandehari

Shuaib

. Atherosclerosis risk factors frequency among North American and Iranian stroke cases. Arya Atherosclerosis J 2008; 3: 121–123.

25.

Emsaki

Molavi

Chitsaz et al.

Psychometric properties of the Montreal Cognitive Assessment (MoCA) in Parkinson's disease patients in Isfahan. J Isfahan Med Sch 2011; 29: 1–10.

26.

Sikaroodi

Yadegari

Miri

. Cognitive impairments in patients with cerebrovascular risk factors: A comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurg 2013; 115: 1276–1280.

27.

Bozorgmanesh

Hadaegh

Azizi

. Predictive accuracy of the ‘Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study. Int J Clin Pract 2011; 65: 264–273.

28.

Wilson

D'Agostino

Levy

et al.

Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1842.

29.

Grodstein

. Cardiovascular risk factors and cognitive function. Alzheimers Dement 2007; 3: S16–S22.

30.

Takeda

JRT

Matos

de Souza-Talarico

JN3

. Cardiovascular risk factors and cognitive performance in aging. Dement Neuropsychol 2017; 11: 442–448.

31.

Kim

Park

. Body mass index and decline of cognitive function. PLoS One 2016; 11: e0148908.

32.

Yin

Zhu

et al.

Blood cholesterol in late-life and cognitive decline: A longitudinal study of the Chinese elderly. Mol Neurodegener 2017; 12: 24.

33.

Arntzen

Schirmer

Wilsgaard

et al.

Impact of cardiovascular risk factors on cognitive function: The Tromsø study. Eur J Neurol 2011; 18: 737–743.

34.

Cukierman-Yaffe

Bosch

Jung

et al.

Hypoglycemia and incident cognitive dysfunction: A post hoc analysis from the ORIGIN trial. Diabetes care 2015; 42: 142–147.

35.

Feinkohl

Keller

Robertson

et al.

Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes. Diabetologia 2015; 58: 1637–1645.

36.

Pavlik

Hyman

Doody

. Cardiovascular risk factors and cognitive function in adults 30–59 years of age (NHANES III). Neuroepidemiology 2005; 24: 42–50.

37.

Dregan

Stewart

Gulliford

. Cardiovascular risk factors and cognitive decline in adults aged 50 and over: A population-based cohort study. Age Ageing 2013; 42: 338–345.

38.

Walther

Birdsill

Glisky

et al.

Structural brain differences and cognitive functioning related to body mass index in older females. Hum Brain Mapp 2010; 31: 1052–1064.

39.

Bums

Duff

. Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci 2002; 977: 367–375.

40.

Wendell

Zonderman

Metter

et al.

Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009; 40: 3180–3185.

41.

Wright

Festa

Paik

et al.

White matter hyperintensities and subclinical infarction associations with psychomotor speed and cognitive flexibility. Stroke 2008; 39: 800–805.

42.

de Haan

Nys

Van Zandvoort

. Cognitive function following stroke and vascular cognitive impairment. Curr Opin Neurol 2006; 19: 559–564.